A Possible Effect of Oxytocin During Interaction Between Humans and Animals (Oxytocin2010)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gunn Pedersen, Norwegian University of Life Sciences
ClinicalTrials.gov Identifier:
NCT01226017
First received: October 20, 2010
Last updated: November 22, 2011
Last verified: November 2011
  Purpose

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals.


Condition Intervention
Animal Assisted Therapy
Other: Measuring oxytocin level in blood

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: A Possible Effect of Oxytocin During Interaction Between Humans and Animals

Resource links provided by NLM:


Further study details as provided by Norwegian University of Life Sciences:

Primary Outcome Measures:
  • Measuring the possible change in Oxytocin level in human blood during intervention with farm animals. [ Time Frame: Start medio October 2010, and end December 2011 (14 months) ] [ Designated as safety issue: No ]
    Blood sampling will be drawn at baseline, before intervention starts, and 5 minutes after start. 3rd sample will be drawn 15 minutes after start. Total time of intervention is 15 minutes.


Secondary Outcome Measures:
  • Self evaluation of anxiety and coping strategies. [ Time Frame: Start medio October 2010, and end December 2011 (14 months) ] [ Designated as safety issue: No ]
    Spielberger State Anxiety Inventory (SSAI) (Spielberger et al, 1979)and Coping Strategies Scale of the Pressure Management Indicator (Williams & Cooper, 1998.


Enrollment: 18
Study Start Date: October 2010
Study Completion Date: November 2011
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Measuring oxytocin level in blood
    Blood sampling and instruments measuring anxiety and stress
    Other Name: Oxytocin
Detailed Description:

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals and filling in instruments measuring anxiety and stress.

  Eligibility

Ages Eligible for Study:   20 Years to 30 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • woman
  • age 20-30 years old
  • physical capable of being in a farm environment and have contact with cows

Exclusion Criteria:

  • pregnancy
  • breastfeeding
  • anxiety for blood sampling
  • anxiety for animals
  • allergies
  • psychiatric diagnoses
  • medication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01226017

Locations
Norway
Norwegian University of Life sciences
Aas, Norway, 1432
Sponsors and Collaborators
Norwegian University of Life Sciences
Investigators
Principal Investigator: Bente Berget, PhD Norwegian University of Life Sciences
  More Information

No publications provided

Responsible Party: Gunn Pedersen, MPh, Norwegian University of Life Sciences
ClinicalTrials.gov Identifier: NCT01226017     History of Changes
Other Study ID Numbers: 2010/1589
Study First Received: October 20, 2010
Last Updated: November 22, 2011
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Norwegian University of Life Sciences:
Oxytocin
Animal Assisted therapy
Farm animals
Healthy nursing students

Additional relevant MeSH terms:
Oxytocin
Oxytocics
Reproductive Control Agents
Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on August 01, 2014